Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Re: SAMe Combined with Antidepressants. » bleauberry

Posted by SLS on May 5, 2008, at 5:01:11

In reply to SAMe Combined with Antidepressants., posted by bleauberry on May 4, 2008, at 18:07:47

I am just wondering, though, if Deplin might actually produce a greater concentration of S-AMe in the locales necessary to produce an antidepressant effect. Deplin pours through the blood-brain barrier unhampered. The other advantage to using Deplin is that its methylation processes consume homocysteine.

Alpert et al. are great investigators of clinically applicable issues.


- Scott

> Came across this at pubmed. It was interesting to see that adding a large dose of SAMe to ssri did not result in serotonin syndrome, and did result in 43% remission of people who had not adequately responded to ssri alone. Despite the usual disclaimer at the bottom indicating a placebo controlled trial is warranted, this small trial did pretty good. I mean, to get a 50% response and 43% remission from any group with one augmentation effort is unusually good.
>
> Depression Clinical and Research Program, Massachusetts General Hospital, Department of Psychiatry, Harvard Medical School, Boston, MA 02114, USA. jalpert@partners.org
>
> BACKGROUND: The purpose of this open trial was to evaluate the safety, tolerability, and efficacy of oral S-adenosyl-L-methionine as an antidepressant adjunct among partial and nonresponders to serotonin reuptake inhibitors or venlafaxine. METHOD: Thirty antidepressant-treated adult outpatients with persisting major depressive disorder received 800 to 1600 mg of S-adenosyl-L-methionine tosylate over a 6-week trial. RESULTS: Intent-to-treat analyses based on the Hamilton Depression Rating Scale revealed a response rate of 50% and a remission rate of 43% following augmentation with S-adenosyl-L-methionine. Gastrointestinal symptoms and headaches were the most common side effects. CONCLUSION: Augmentation of selective serotonin reuptake inhibitors or venlafaxine with S-adenosyl-L-methionine warrants a placebo-controlled trial in resistant depression.
>
> PMID: 15538131 [PubMed - indexed for MEDLINE]
>

 

Thread

 

Post a new follow-up

Your message only Include above post


Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.

 

Start a new thread

 
Google
dr-bob.org www
Search options and examples
[amazon] for
in

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:SLS thread:827188
URL: http://www.dr-bob.org/babble/20080430/msgs/827277.html